Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR5A1 | Q13285 | 1/20 | 0.60 |
| ▸ | LTA4H | P09960 | 4/20 | 0.53 |
| ▸ | TP53 | P04637 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | PLA2G4B | P0C869 | 3/20 | 0.51 |
| ▸ | RARB | P10826 | 3/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL659360 | 1.00 | NR5A1 (0.60) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL338316 | 1.00 | NR5A1 (0.60) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL1609987 | 1.00 | NR5A1 (0.60) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL1611001 | 1.00 | NR5A1 (0.60) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL309133 | 1.00 | NR5A1 (0.60) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL987954 | 1.00 | NR5A1 (0.60) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL77477 | 1.00 | NR5A1 (0.60) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL9121701 | 1.00 | NR5A1 (0.60) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL263776 | 1.00 | NR5A1 (0.60) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL988767 | 1.00 | NR5A1 (0.60) | NR5A1LTA4HTP53TSHRPLA2G4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108383980-B | Thermally induced delayed fluorescence polymer with main chain containing diphenyl silicon and carbazole units and preparation method thereof | 中国科学院长春应用化学研究所 | 2020-07-07 | — | — | CN | claimed |
| EP-0003663-A2 | Amino-substituted phenyl and heteroaryl compounds, process for their preparation and pharmaceutical compositions containing them | AMERICAN CYANAMID COMPANY (US) | 1979-08-22 | — | — | EP | claimed |
| CN-118302407-A | Carbonyl compound, method for producing isocyanate compound, and isocyanate composition | 旭化成株式会社 | 2024-07-05 | — | — | CN | disclosed |
| CN-108383980-B | Thermally induced delayed fluorescence polymer with main chain containing diphenyl silicon and carbazole units and preparation method thereof | 中国科学院长春应用化学研究所 | 2020-07-07 | — | — | CN | disclosed |
| CN-109593192-B | Polyarylether/polyarylene sulfide with heat-activated delayed fluorescence effect and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2020-04-03 | — | — | CN | disclosed |
| EP-2248818-B1 | ORGANIC SEMICONDUCTOR MATERIAL | SUMITOMO CHEMICAL CO (JP) | 2014-09-24 | — | — | EP | disclosed |
| US-20110087034-A1 | Organic Semiconductor Material | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2011-04-14 | — | — | US | disclosed |
| EP-2248818-A1 | ORGANIC SEMICONDUCTOR MATERIAL | Sumitomo Chemical Company, Limited (JP) | 2010-11-10 | — | — | EP | disclosed |
| US-7691898-B2 | Phosphonic acid derivatives and the treating agents of diseases related hyperphosphatemia | KOTOBUKI PHARMACEUTICAL CO., LTD. (JP) | 2010-04-06 | — | — | US | disclosed |
| US-20080119441-A1 | Phosphonic Acid Derivatives and the Treating Agents of Diseases Related Hyperphosphatemia | KOTOBUKI PHARMACEUTICAL CO., LTD. (JP) | 2008-05-22 | — | — | US | disclosed |
| EP-1813620-A1 | PHOSPHONIC ACID DERIVATIVE AND THERAPEUTIC AGENT FOR DISEASE IN WHICH HIGH PHOSPHATE LEVEL IN BLOOD PARTICIPATES | Kotobuki Pharmaceutical Co., Ltd. (JP) | 2007-08-01 | — | — | EP | disclosed |
| US-4980081-A | Polymers which form liquid-crystalline phases | BASF AKTIENGESELLSCHAFT (DE) | 1990-12-25 | — | — | US | disclosed |
| EP-0385329-A2 | Polymeric discotic liquid crystalline charge transfer complexes, their preparation and their use | BASF Aktiengesellschaft (DE) | 1990-09-05 | — | — | EP | disclosed |
| US-4865762-A | Polymers which form liquid-crystalline phases | BASF AKTIENGESELLSCHAFT (DE) | 1989-09-12 | — | — | US | disclosed |
| EP-0140133-B1 | LIQUID CRYSTAL PHASE-FORMING POLYMERS | BASF Aktiengesellschaft (DE) | 1988-08-10 | — | — | EP | disclosed |
| WO-1988000581-A1 | PREPARATION OF CARBOXYPROPYLATED NON-IONIC SURFACTANTS | GAF CORPORATION (US) | 1988-01-28 | — | — | WO | disclosed |
| US-4692551-A | SALT FORMATION OF ALCOHOL ETHER WITH METAL HYDROXIDE, REACTING SALT WITH A BUTYROLACTONE | GAF CORPORATION (US) | 1987-09-08 | — | — | US | disclosed |
| EP-0140133-A2 | Liquid crystal phase-forming polymers | BASF Aktiengesellschaft (DE) | 1985-05-08 | — | — | EP | disclosed |
| US-4211783-A | Hypolipidemic and antiatherosclerotic novel 4-(aralkyl- and heteroarylalkylamino)phenyl compounds | AMERICAN CYANAMID COMPANY (US) | 1980-07-08 | — | — | US | disclosed |
| EP-0003663-A2 | Amino-substituted phenyl and heteroaryl compounds, process for their preparation and pharmaceutical compositions containing them | AMERICAN CYANAMID COMPANY (US) | 1979-08-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110087034-A1 | Organic Semiconductor Material | OR10J3, TST, OR51E2 | NR5A1 341/4885LTA4H 1835/4885TP53 1684/4885 |
| US-20080119441-A1 | Phosphonic Acid Derivatives and the Treating Agents of Diseases Related Hyperphosphatemia | NR0B1, NR0B2, PTH1R | NR5A1 41/4885LTA4H 3113/4885TP53 2526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.